Company / Current Assets per Share
Vera Therapeutics, Inc. Current Assets per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$11.35
FY2025
5-year range
$4.03 / $11.77
FY2021-FY2025
Trend
-3.6%
vs FY2024
Sector context
#66 of 210
Health Care
What the data says
At $11.35, Vera Therapeutics, Inc.'s current assets per share ranks #66 of 210 in the Health Care sector. Improved from $4.03 to $11.35 over the past 2 years.
Based on SEC 10-K filings.
11.35 in FY2025 with a 5-year CAGR of -41.8%.
Improved from $4.03 to $11.35 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +33.9%
- 5-Year CAGR
- -41.8%
- 10-Year CAGR
- -
Sector benchmark
#66 of 210 in Health CareTop 31% of 210This company $11.35 Sector average $170.65
▼
-93.4% below sector average
Key checks
Key Insights
- In FY2025, current assets per share decreased 3.6% year-over-year.
- Ranks #66 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2020.
- Lowest current assets per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.35 | -3.6% |
| FY2024 | $11.77 | +192.2% |
| FY2023 | $4.03 | -14.9% |
| FY2022 | $4.73 | -23.0% |
| FY2021 | $6.14 | -96.4% |
| FY2020 | $169.59 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026